Our present and previous human postmortem brain studies [29–31] not only suggest that alterations in ERK1/2 may be important in the pathophysiology of depression but also raise the interesting possibility that ERK1/2 may be involved in generating vulnerability to depression phenotype. This evidence concerns the gene MAPK3 and major depressive disorder.